Rubric Capital Management LP

Institutional investor · Portfolio as of Q2 2023

Q2 2023 biggest moves
  • VTRSVTRS

    Viatris

    New

    5.1% of stocks

  • TEVATEVA

    Teva Pharmaceutical Industries

    4.2× the shares

    now 6.0% of stocks

  • STNGSTNG

    Scorpio Tankers

    Cut 57%

    now 2.1% of stocks

  • CCJCCJ

    Cameco

    Cut 43%

    now 3.6% of stocks

65 changes in all

Top Holdings62 positions

Checking export access…
Activity:
TEVA
TEVA
ADR

Teva Pharmaceutical Industries Limited

18.7M$140.9M6.0%$7.85-4.04%
2 qtrssince 2023-Q1
Increased
95
GLNG

Golar LNG Limited

6.5M$130.2M5.6%$11.85+54.01%
9 qtrssince 2021-Q2
Decreased
0
VTRS

Viatris Inc.

12M$119.3M5.1%$8.700.00%
1 qtr
New
93
HTZ

Hertz Global Holdings, Inc

5.7M$105.2M4.5%$24.99-26.41%
7 qtrssince 2021-Q4
Decreased
0
FLR

Fluor Corporation

3.4M$101.1M4.3%$25.33+16.88%
7 qtrssince 2021-Q4
Increased
57
COOP
COOPDelisted

MR COOPER GROUP INC

2M$99.5M4.3%——
15 qtrssince 2019-Q4
Increased
62
BGCP
BGCPDelisted

BGC PARTNERS INC

20M$88.6M3.8%——
15 qtrssince 2019-Q4
Increased
55
CCJ

Cameco Corporation

2.7M$84.4M3.6%$25.83+20.58%
3 qtrssince 2022-Q4
Decreased
0
VST

Vistra Corp.

2.8M$73.8M3.2%$23.36+8.87%
2 qtrssince 2023-Q1
Increased
62
COLL

Collegium Pharmaceutical, Inc.

3.4M$73.6M3.1%$18.57+15.70%
14 qtrssince 2020-Q1
Increased
57
PARR

Par Pacific Holdings, Inc.

2.7M$71.7M3.1%$10.54+152.38%
13 qtrssince 2020-Q2
Decreased
0
AIR

AAR Corp.

1.2M$71M3.0%$37.80+52.81%
11 qtrssince 2020-Q4
Decreased
0
PLYA
PLYADelisted

PLAYA HOTELS & RESORTS NV

7.2M$58.7M2.5%——
11 qtrssince 2020-Q4
Decreased
0
MATV

Mativ Holdings, Inc.

3.4M$52M2.2%$18.10-25.83%
4 qtrssince 2022-Q3
Increased
53
LC

HAPPEN INC

5.3M$51.8M2.2%$13.04-53.22%
6 qtrssince 2022-Q1
Decreased
0
ADEA

Adeia Inc.

4.6M$50.6M2.2%$8.94+17.45%
3 qtrssince 2022-Q4
Unchanged
0
XPER

Xperi Inc.

3.8M$50.5M2.2%——
3 qtrssince 2022-Q4
Unchanged
0
DOLE

Dole plc

3.6M$49.2M2.1%$7.49+68.79%
4 qtrssince 2022-Q3
Decreased
0
STNG

Scorpio Tankers Inc.

1M$48.8M2.1%$51.13-2.87%
2 qtrssince 2023-Q1
Decreased
0
KNSA

Kiniksa Pharmaceuticals International, plc

3.4M$47.6M2.0%———
—
$2.3B
AUM
62
Positions
Q2 2023
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2022-Q1$2,765,454,00030.6799962007%
2022-Q2$1,903,702,000-31.1613210706%
2022-Q3$1,985,236,0004.28291822985%
2022-Q4$2,293,709,71615.5383901964%
2023-Q1$3,856,770,89568.1455533844%
2023-Q2$2,338,598,459-39.3638221541%
Activity profile
$ moved · Q2'23
New9%Increased10%Decreased13%Exited68%
Composition
Equity vs derivatives
Equity>99%Puts<1%Calls0%
Holding period
Avg 1.7 years
<1Q13%1-4Q19%1-2Y18%2Y+50%

Rubric Capital Management LP manages $2.3B across 62 positions as of Q2 2023. Top holdings: TEVA (6.0%), GLNG (5.6%), VTRS (5.1%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$2B
TEVA6.03%
GLNG5.57%
VTRS5.10%
HTZ4.50%
FLR4.32%
COOP4.26%
BGCP3.79%
CCJ3.61%
VST3.16%
COLL3.15%
Other3.07%

Portfolio allocation by GICS sector

Sectors11
Healthcare32.83%
Energy14.35%
Unknown14.03%
Industrials12.37%
Utilities7.55%
Technology5.77%
Basic Materials5.42%
Communication Services2.73%
Financial Services2.72%
Consumer Defensive2.11%
Other0.14%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Healthcare, Energy, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L34
Conviction64
Concentration69
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
GEOGEOThe Geo Group Inc
Q2 2025 → Q3 2026+4.5M shares+$138.3M
5Q
BGCBGCBGC Group, Inc.
Q3 2025 → Q3 2026+9.3M shares+$129.2M
5Q
VTRSVTRSViatris Inc.
Q3 2025 → Q3 2026+24M shares+$530.8M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used